Gemcitabine ‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes
ConclusionsThe GBM/GBC regimen is effective and well-tolerated, offering outcomes that are highly comparable to those in NHL patients conditioned with BEAM/BEAC, as demonstrated in a prognostically matched cohort. (Source: Cancer Medicine)
Source: Cancer Medicine - February 1, 2024 Category: Cancer & Oncology Authors: Huimin Liu,
Hesong Zou,
Dandan Shan,
Wei Liu,
Wenyang Huang,
Weiwei Sui,
Shuhui Deng,
Tingyu Wang,
Rui Lv,
Mingwei Fu,
Yan Xu,
Shuhua Yi,
Gang An,
Yaozhong Zhao,
Lugui Qiu,
Dehui Zou Tags: RESEARCH ARTICLE Source Type: research
Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review
ConclusionsPatient education by knowledgeable and confident HCPs, information management and a caring patient-HCP relationship communicating continuity of care regardless of cBT results are crucial to empower patients and shared decision-making in precision oncology. More data on the process and structure of cBT-related communication, distinction between and characterization of different timepoints of patient-HCP interactions are needed. (Source: Cancer Medicine)
Source: Cancer Medicine - February 1, 2024 Category: Cancer & Oncology Authors: Theresia Pichler,
Friederike Mumm,
Navdeep Dehar,
Erin Dickman,
Celia D íez de Los Ríos de la Serna,
Andreas Dinkel,
Kathrin Heinrich,
Merel Hennink,
Anndra D. Parviainen,
Vincent Raske,
Nicole Wicki,
Amy C. Moore Tags: REVIEW Source Type: research
Issue Information
(Source: Cancer Medicine)
Source: Cancer Medicine - January 31, 2024 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research
Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
ConclusionsMVI was found to be substantially linked with four subgroups of HCC patients with hepatocirrhosis, positive AFP, tumor diameter>50 mm, and LMR ≤3.4, and the prognosis of MVI-positive patients in all four subgroups tended to be worse. (Source: Cancer Medicine)
Source: Cancer Medicine - January 30, 2024 Category: Cancer & Oncology Authors: Jilin Yang,
Junlin Qian,
Zhao Wu,
Wenjian Zhang,
Zexin Yin,
Wei Shen,
Kun He,
Yongzhu He,
Liping Liu Tags: RESEARCH ARTICLE Source Type: research
Predicting survival in patients with buccal cancer: A study based on SEER database and external validation in China
ConclusionsThe nomograms developed with great performance predicted 1-, 3-, and 5-year OS and CSS of BMC patients. Use of the nomograms in clinical practices shall bring significant benefits to BMC patients. (Source: Cancer Medicine)
Source: Cancer Medicine - January 29, 2024 Category: Cancer & Oncology Authors: Yongmei Tan,
Guoxing Huang,
Jintao Hu,
Shaoping Zhao,
Yanyan Li,
Zhihui Wen,
Liansheng Wang,
Suling Chen,
Rongxi Chen,
Haotian Cao,
Jinsong Li Tags: RESEARCH ARTICLE Source Type: research
Beyond 5 ‐year survival. A report from the Cooperative Osteosarcoma Study Group (COSS)
ConclusionThis benchmark analysis clearly defined risk factors for the further course of 5-year survivors from osteosarcoma. It argues for large disease-oriented databases as well as for very long follow-up periods. Novel findings will most likely require innovative statistical models to analyze such cohorts. (Source: Cancer Medicine)
Source: Cancer Medicine - January 29, 2024 Category: Cancer & Oncology Authors: Julia S. Fernandes,
Claudia Blattmann,
Stefanie Hecker ‐Nolting,
Leo Kager,
Matthias Kevric,
Vanessa Mettmann,
Benjamin Sorg,
Marc Fernandes,
Stefan S. Bielack Tags: RESEARCH ARTICLE Source Type: research
LGBTQ+ inequity in crowdfunding cancer costs: The influence of online reach and LGBTQ+ state policy
Conclusions and RelevanceOur findings revealed LGBTQ+ inequity in cancer-related crowdfunding, suggesting that LGBTQ+ cancer survivors may be less able to address financial burden via crowdfunding in comparison to non-LGBTQ+ cancer survivors —potentially widening existing economic inequities. (Source: Cancer Medicine)
Source: Cancer Medicine - January 26, 2024 Category: Cancer & Oncology Authors: Austin R. Waters,
Caleb W. Easterly,
Cindy Turner,
Lauren Ghazal,
Ida Tovar,
Megan Mulvaney,
Matt Poquadeck,
Stephen A. Rains,
Kristin G. Cloyes,
Anne C. Kirchhoff,
Erin E. Kent,
Echo L. Warner Tags: RESEARCH ARTICLE Source Type: research
Analysis of translesion polymerases in colorectal cancer cells following cetuximab treatment: A network perspective
ConclusionWe found that translesion polymerases are co-regulated with DNA mismatch repair and cell cycle-associated factors. We did not, however, identified any networks specific to cetuximab treatment indicating that the response to EGFR inhibitors relates to a general stress response mechanism. (Source: Cancer Medicine)
Source: Cancer Medicine - January 25, 2024 Category: Cancer & Oncology Authors: Anubrata Das,
Georgios V. Gkoutos,
Animesh Acharjee Tags: RESEARCH ARTICLE Source Type: research
The incremental healthcare cost associated with cancer in Belgium: A registry ‐based data analysis
ConclusionsIn our study, the direct attributable cost of the most prevalent cancer sites in Belgium was estimated to provide useful guidance for cost containment policies. Many of these cancers could be prevented by tackling risk factors such as smoking, obesity, and environmental stressors. (Source: Cancer Medicine)
Source: Cancer Medicine - January 25, 2024 Category: Cancer & Oncology Authors: Vanessa Gorasso,
Stefanie Vandevijvere,
Johan Van der Heyden,
Ingrid Pelgrims,
Henk Hilderink,
Wilma Nusselder,
Claire Demoury,
Masja Schmidt,
Stijn Vansteelandt,
Delphine De Smedt,
Brecht Devleesschauwer Tags: RESEARCH ARTICLE Source Type: research
Target volumes comparison between postoperative simulation magnetic resonance imaging and preoperative diagnostic magnetic resonance imaging for prone breast radiotherapy after breast ‐conserving surgery
ConclusionsDespite using DIR technology, the spatial correspondence of target volumes between MRIpre and MRIpost was suboptimal. Therefore, relying solely on preoperative diagnostic MRI with DIR for postoperative LC delineation is not recommended. (Source: Cancer Medicine)
Source: Cancer Medicine - January 22, 2024 Category: Cancer & Oncology Authors: Ying Jin,
Changhui Zhao,
Lizhen Wang,
Ya Su,
Dongping Shang,
Fengxiang Li,
Jinzhi Wang,
Xijun Liu,
Jianbin Li,
Wei Wang Tags: RESEARCH ARTICLE Source Type: research
A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study
ConclusionOver the last decade, at least one quarter of LA/RM HNC and half of OPC cases studied in IS and NIS were HPV+. This alarming burden is consistent with a potential implication of HPV in the pathogenesis of at least a subgroup of HNC, underscoring the relevance of HPV testing and prophylaxis to HNC prevention and management. (Source: Cancer Medicine)
Source: Cancer Medicine - January 22, 2024 Category: Cancer & Oncology Authors: Sofia Agelaki,
Ioannis Boukovinas,
Ilias Athanasiadis,
Georgios Trimis,
Ioannis Dimitriadis,
Lazaros Poughias,
Edith Morais,
Ugne Sabale,
Goran Bencina,
Charalampos Athanasopoulos Tags: REVIEW Source Type: research
Retinoblastoma treatment in a Brazilian population. Presentation and long ‐term results
ConclusionsTreatment of retinoblastoma with conservative systemic-based chemotherapy was associated with an excellent survival rate (92%). Albeit the low overall globe salvage rate, in BIL patients, approximately half the eyes were conserved, and a satisfactory functional visual result was achieved The evaluated protocol is an important treatment option, especially in developing countries. (Source: Cancer Medicine)
Source: Cancer Medicine - January 20, 2024 Category: Cancer & Oncology Authors: Maria Teresa Brizzi Chizzotti Bonanomi,
Maria Tereza A. de Almeida,
Marianna A. Hollaender,
Roberta Chizzotti Bonanomi,
Mario Luiz Ribeiro Monteiro Tags: RESEARCH ARTICLE Source Type: research
Issue Information
(Source: Cancer Medicine)
Source: Cancer Medicine - January 19, 2024 Category: Cancer & Oncology Tags: ISSUE INFORMATION Source Type: research
Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews
ConclusionsThe evidence-base on ET adherence determinants is extensive. Future empirical studies should focus on less well-researched areas and settings. The determinants themselves are numerous and complex in indicating that adherence support should be multifaceted, addressing multiple determinants. (Source: Cancer Medicine)
Source: Cancer Medicine - January 19, 2024 Category: Cancer & Oncology Authors: Adam Todd,
Catherine Waldron,
Lucy McGeagh,
Ruth Norris,
Iakov Bolnykh,
Sarah Jane Stewart,
Joanna Slodkowska ‐Barabasz,
Zoe Moon,
Caitriona Cahir,
Sue Thompson,
Victoria Harmer,
Mary Wells,
Eila Watson,
Linda Sharp,
the SWEET Research Tea Tags: RESEARCH ARTICLE Source Type: research
Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome
ConclusionChildren with Down syndrome (DS) are at increased risk for developing acute leukemia compared to the general population but are systematically excluded from neurocognitive outcome studies among leukemia survivors. This study demonstrated the feasibility of evaluating neurocognitive late effects in leukemia survivors with DS using novel measures appropriate for populations with intellectual developmental disorder. (Source: Cancer Medicine)
Source: Cancer Medicine - January 19, 2024 Category: Cancer & Oncology Authors: Kellen Gandy,
Lacey Hall,
Kevin R. Krull,
Anna J. Esbensen,
Jeffrey Rubnitz,
Lisa M. Jacola Tags: RESEARCH ARTICLE Source Type: research
